Our Team
Gaurav Aggarwal, M.D.
Principal
Dr. Aggarwal is a Principal at Panorama Capital and focuses on life sciences investments. He currently serves on the board of directors of Flowcardia and Hyperion Therapeutics, and was previously on the board of directors at PIramed and Microscience Investments Limited. Dr. Aggarwal was closely involved in the firm’s investments in Amarin Corporation and Presidio Pharmaceuticals. He was previously employed by KBL Healthcare Ventures, most recently as Vice President, where he also focused on venture capital investments in biopharmaceutical and medical device companies. Dr. Aggarwal was involved with KBL's investments in Avalon Pharmaceuticals, ISTA Pharmaceuticals, Neuronetics, and Spinal Concepts, and was a board observer at each company. He was also involved with KBL's investments in Achillion Pharmaceuticals, Corixa Corporation and Scynexis. From 1997 to 1999, Dr. Aggarwal was in the venture capital group at Wasserstein Perella & Co. Dr. Aggarwal received his M.D. from Columbia University, College of Physicians & Surgeons and his B.S. in Business Management from Cornell University.